Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Dynamic changes in the CD163+ and CCR2+ peripheral monocytes during Parkinson’s disease

View ORCID ProfileSara Konstantin Nissen, View ORCID ProfileKristine Farmen, View ORCID ProfileMikkel Carstensen, View ORCID ProfileClaudia Schulte, David Goldeck, View ORCID ProfileKathrin Brockmann, View ORCID ProfileMarina Romero-Ramos
doi: https://doi.org/10.1101/2021.03.15.21253572
Sara Konstantin Nissen
1DANDRITE & Department of Biomedicine, Aarhus University, Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sara Konstantin Nissen
Kristine Farmen
1DANDRITE & Department of Biomedicine, Aarhus University, Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kristine Farmen
Mikkel Carstensen
1DANDRITE & Department of Biomedicine, Aarhus University, Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mikkel Carstensen
Claudia Schulte
2Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research & German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Claudia Schulte
David Goldeck
3Department of Internal Medicine II, Centre for Medical Research, University of Tuebingen, Tuebingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathrin Brockmann
2Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research & German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kathrin Brockmann
Marina Romero-Ramos
1DANDRITE & Department of Biomedicine, Aarhus University, Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marina Romero-Ramos
  • For correspondence: mrr@biomed.au.dk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Alpha-synuclein aggregates and accumulation are associated with immune activation and neurodegeneration in Parkinson’s disease. The immune activation is not only dependent on the brain-resident microglial cells but also involves peripheral immune cells, such as mononuclear phagocytes including monocytes and dendritic cells, found in the blood as well as infiltrated into the brain. Understanding the involvement of the peripheral immune component in Parkinson’s disease is essential for the development of immunomodulatory treatment, which might modify disease progression. We aimed to study the profile of circulating mononuclear phagocytes in early- and late-stage Parkinson’s disease by analyzing surface-expressed molecules related to phagocytosis, alpha-synuclein sensing, and tissue-migration.

Methods Multi-color flow cytometry on peripheral mononuclear cells from cross-sectional samples of 80 gender-balance individuals with early- and late-stage sporadic Parkinson’s disease, and 29 controls, as well as longitudinal samples from seven patients and one control. Cells were delineated into natural killer cells, monocyte subtypes, and dendritic cells with cell frequencies and surface marker expressions compared between patients and controls, and correlated with standardized clinical motor and non-motor scores.

Results Overall, we found elevated frequencies and surface levels of markers related to migration (CCR2, CD11b) and phagocytosis (CD163) particularly on the elevated classical and intermediate monocytes in patients with Parkinson’s disease for less than five years. This corresponded to a decrease of non-classical monocytes and dendritic cells. We observed an increased HLA-DR expression late in disease and sexual-dimorphism with TLR-4 expression decreased in women with PD but not in males. The disease-associated immune changes on TLR4, CCR2, and CD11b were correlated with non-motor symptoms such as olfaction or cognition. While many alterations were normalized at late disease stage, other changes remained, such as the increased HLA-DR and CD163 expressions.

Conclusions Our data highlight a role for peripheral CD163+ and migration-competent classical monocytes in Parkinson’s disease. The study further suggests that the peripheral immune system is dynamically altered in Parkinson’s disease stages and directly related to both non-motor symptoms and the sex-bias of the disease.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Funding support for the research covered by this article was provided by the Michael J. Fox Foundation (MRR), the Bjarne Saxhof Fund administered through the Danish Parkinson's Foundation (MRR) and the Danish Council for Independent Research (MRR).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the Ethics Committee of the University of Tuebingen (Germany) committee (480/2015BO2).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵A) sarakn{at}biomed.au.dk

  • ↵B) kristine.farmen{at}outlook.com

  • ↵C) micg{at}biomed.au.dk

  • ↵D) claudia.schulte{at}uni-tuebingen.de

  • ↵E) dgoldeck{at}yahoo.de

  • ↵F) kathrin.brockmann{at}uni-tuebingen.de

Data Availability

The data supporting the conclusions are included within the article and its additional file.

  • List of abbreviations

    (α-syn)
    alpha-synuclein
    (BDI-II)
    Beck Depression Inventory
    (cDC1)
    conventional DC type 1
    (cDC2)
    conventional DC type 2
    (cMo)
    classical monocyte
    (CNS)
    central nervous system
    (DC)
    dendritic cell
    (HC)
    healthy control
    (iMo)
    intermediate monocyte
    (LEDD)
    Levodopa equivalent daily dosage
    (MoCA)
    Montreal Cognitive Assessment
    (MFI)
    median fluorescence intensity
    (MNP)
    peripheral mononuclear phagocyte
    (Mo)
    monocytes
    (ncMo)
    macrophage (Mϕ, non-classical monocyte
    (NK)
    natural killer
    (PBMCs)
    Peripheral blood mononuclear cells
    (pDCs)
    plasmacytoid
    (PD)
    Parkinson’s disease
    (PwP)
    people with PD
    (REML)
    repeated-measures mixed-effect model
    (TLR)
    toll-like receptor
    (tSNE)
    t-distributed stochastic neighbor embedding
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted March 17, 2021.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Dynamic changes in the CD163+ and CCR2+ peripheral monocytes during Parkinson’s disease
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Dynamic changes in the CD163+ and CCR2+ peripheral monocytes during Parkinson’s disease
    Sara Konstantin Nissen, Kristine Farmen, Mikkel Carstensen, Claudia Schulte, David Goldeck, Kathrin Brockmann, Marina Romero-Ramos
    medRxiv 2021.03.15.21253572; doi: https://doi.org/10.1101/2021.03.15.21253572
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    Dynamic changes in the CD163+ and CCR2+ peripheral monocytes during Parkinson’s disease
    Sara Konstantin Nissen, Kristine Farmen, Mikkel Carstensen, Claudia Schulte, David Goldeck, Kathrin Brockmann, Marina Romero-Ramos
    medRxiv 2021.03.15.21253572; doi: https://doi.org/10.1101/2021.03.15.21253572

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Neurology
    Subject Areas
    All Articles
    • Addiction Medicine (164)
    • Allergy and Immunology (416)
    • Anesthesia (92)
    • Cardiovascular Medicine (867)
    • Dentistry and Oral Medicine (159)
    • Dermatology (98)
    • Emergency Medicine (251)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (397)
    • Epidemiology (8589)
    • Forensic Medicine (4)
    • Gastroenterology (390)
    • Genetic and Genomic Medicine (1772)
    • Geriatric Medicine (169)
    • Health Economics (375)
    • Health Informatics (1252)
    • Health Policy (625)
    • Health Systems and Quality Improvement (472)
    • Hematology (197)
    • HIV/AIDS (380)
    • Infectious Diseases (except HIV/AIDS) (10344)
    • Intensive Care and Critical Care Medicine (553)
    • Medical Education (193)
    • Medical Ethics (51)
    • Nephrology (214)
    • Neurology (1692)
    • Nursing (97)
    • Nutrition (252)
    • Obstetrics and Gynecology (330)
    • Occupational and Environmental Health (451)
    • Oncology (933)
    • Ophthalmology (265)
    • Orthopedics (104)
    • Otolaryngology (172)
    • Pain Medicine (115)
    • Palliative Medicine (40)
    • Pathology (255)
    • Pediatrics (539)
    • Pharmacology and Therapeutics (257)
    • Primary Care Research (210)
    • Psychiatry and Clinical Psychology (1785)
    • Public and Global Health (3871)
    • Radiology and Imaging (627)
    • Rehabilitation Medicine and Physical Therapy (322)
    • Respiratory Medicine (525)
    • Rheumatology (208)
    • Sexual and Reproductive Health (170)
    • Sports Medicine (158)
    • Surgery (191)
    • Toxicology (36)
    • Transplantation (101)
    • Urology (76)